MET kinase-IN-2
MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM. MET kinase-IN-2 has antitumor activity[1].
Product Specifications
CAS Number
[2101241-90-9]
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/met-kinase-in-2.html
Purity
98.39
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C(C2=CC=CC=C2)=CNC3=C1C(NC4=CC=C(OC5=CC=NC6=CC(OCC(C)(O)C)=CC=C56)C(F)=C4)=NC=C3
Molecular Formula
C33H27FN4O4
Molecular Weight
562.59
References & Citations
[1]Chen T, et al. Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate. Eur J Med Chem. 2020;192:112174.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal DHX36 Antibody [FITC]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
GTR15196156 1 Vial
Lentiviral mouse 4932429P05Rik shRNA (UAS) - Lentiviral mouse 4932429P05Rik shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details TL508335V 500 µL Each
Sycp2 Mouse shRNA Lentiviral Particle (Locus ID 320558)
Sign In for Pricing
View Details 